ACELYRIN, INC Net Worth
ACELYRIN, INC Net Worth Breakdown | SLRN |
ACELYRIN, INC Net Worth Analysis
ACELYRIN, INC's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including ACELYRIN, INC's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of ACELYRIN, INC's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform ACELYRIN, INC's net worth analysis. One common approach is to calculate ACELYRIN, INC's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares ACELYRIN, INC's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing ACELYRIN, INC's net worth. This approach calculates the present value of ACELYRIN, INC's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of ACELYRIN, INC's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate ACELYRIN, INC's net worth. This involves comparing ACELYRIN, INC's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into ACELYRIN, INC's net worth relative to its peers.
To determine if ACELYRIN, INC is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ACELYRIN, INC's net worth research are outlined below:
ACELYRIN, INC Common had very high historical volatility over the last 90 days | |
ACELYRIN, INC Common has high likelihood to experience some financial distress in the next 2 years | |
Net Loss for the year was (381.64 M) with profit before overhead, payroll, taxes, and interest of 0. | |
ACELYRIN, INC generates negative cash flow from operations | |
ACELYRIN, INC Common has a poor financial position based on the latest SEC disclosures | |
Over 99.0% of the company shares are owned by institutional investors | |
Latest headline from MacroaxisInsider: Acquisition by Murugan Amar of 525000 shares of ACELYRIN, INC at 4.73 subject to Rule 16b-3 |
ACELYRIN, INC uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ACELYRIN, INC Common. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ACELYRIN, INC's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024 Upcoming Quarterly Report | View | |
20th of June 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
6th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Follow ACELYRIN, INC's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 458.49 M.Market Cap |
|
Project ACELYRIN, INC's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.51) | (0.54) | |
Return On Capital Employed | (0.64) | (0.67) | |
Return On Assets | (0.51) | (0.54) | |
Return On Equity | (0.58) | (0.55) |
When accessing ACELYRIN, INC's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures ACELYRIN, INC's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ACELYRIN, INC's profitability and make more informed investment decisions.
Evaluate ACELYRIN, INC's management efficiency
ACELYRIN, INC Common has return on total asset (ROA) of (0.3289) % which means that it has lost $0.3289 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4195) %, meaning that it created substantial loss on money invested by shareholders. ACELYRIN, INC's management efficiency ratios could be used to measure how well ACELYRIN, INC manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of November 2024, Return On Tangible Assets is likely to drop to -0.54. In addition to that, Return On Capital Employed is likely to drop to -0.67. At this time, ACELYRIN, INC's Other Assets are very stable compared to the past year. As of the 29th of November 2024, Other Current Assets is likely to grow to about 11.1 M, while Total Assets are likely to drop about 431.9 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 9.34 | 9.81 | |
Tangible Book Value Per Share | 9.34 | 9.81 | |
Enterprise Value Over EBITDA | (0.81) | (0.85) | |
Price Book Value Ratio | 0.80 | 0.84 | |
Enterprise Value Multiple | (0.81) | (0.85) | |
Price Fair Value | 0.80 | 0.84 | |
Enterprise Value | 276.4 M | 245.7 M |
The strategic initiatives led by ACELYRIN, INC's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Return On Equity (0.42) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ACELYRIN, INC insiders, such as employees or executives, is commonly permitted as long as it does not rely on ACELYRIN, INC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ACELYRIN, INC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ACELYRIN, INC Corporate Filings
F4 | 27th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 22nd of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 13th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
ACELYRIN, INC Earnings per Share Projection vs Actual
ACELYRIN, INC Corporate Management
Patricia Turney | Chief Officer | Profile | |
Kenneth Lock | Chief Officer | Profile | |
Gilbert JD | Principal Officer | Profile | |
Shephard MD | Senior Development | Profile | |
Kelly Chow | Chief Officer | Profile | |
Ron Oyston | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ACELYRIN, INC Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACELYRIN, INC. If investors know ACELYRIN, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACELYRIN, INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.46) | Return On Assets (0.33) | Return On Equity (0.42) |
The market value of ACELYRIN, INC Common is measured differently than its book value, which is the value of ACELYRIN, that is recorded on the company's balance sheet. Investors also form their own opinion of ACELYRIN, INC's value that differs from its market value or its book value, called intrinsic value, which is ACELYRIN, INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACELYRIN, INC's market value can be influenced by many factors that don't directly affect ACELYRIN, INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACELYRIN, INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if ACELYRIN, INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACELYRIN, INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.